Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05077800
What this trial is testing

FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaPancreatic Adenocarcinoma Metastatic
Colin D. Weekes, M.D., PhD 70
Testing effectiveness (Phase 2)Study completedNCT00719212
What this trial is testing

Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Translational Research in Oncology 61
Testing effectiveness (Phase 2)Study completedNCT01736410
What this trial is testing

Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

Who this might be right for
HER 2 Positive Advanced Gastric Cancer
National Cancer Centre, Singapore 30
Not applicableEnded earlyNCT00504218
What this trial is testing

Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
HypopituitarismHypogonadismThyroid Dysfunction+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 62
Not applicableUnknownNCT03411590
What this trial is testing

The Effect of Fortified Growing-up Milk on Growth and Micronutrient Status of Nigerian Toddlers

Who this might be right for
Malnutrition; MildIron-deficiency AnemiaNutritional Stunting+3 more
FrieslandCampina WAMCO Nigeria PLC 150
Testing effectiveness (Phase 2)UnknownNCT03904823
What this trial is testing

Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLC

Who this might be right for
EGFR-mutant Non-Small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 58
Testing effectiveness (Phase 2)Study completedNCT01783444
What this trial is testing

A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 309
Not applicableNot Yet RecruitingNCT07714304
What this trial is testing

JS212 in Combination With JS111 as First-Line Treatment in EGFR-Mutant Advanced NSCLC

Who this might be right for
NSCLC Harboring EGFR Mutations
Huan Zhou 20
Testing effectiveness (Phase 2)Study completedNCT05963984
What this trial is testing

Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast CancerBreast Cancer
Carrick Therapeutics Limited 60
Not applicableStudy completedNCT03137264
What this trial is testing

Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive Patients

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 44
Early research (Phase 1)WithdrawnNCT06341647
What this trial is testing

Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201

Who this might be right for
Breast CancerGastric CancerGastroesophageal Junction Adenocarcinoma
GC Cell Corporation
Early research (Phase 1)Active Not RecruitingNCT05567185
What this trial is testing

Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer

Who this might be right for
Urinary Bladder NeoplasmsReceptors, Fibroblast Growth Factor
Janssen Pharmaceutical K.K. 5
Not applicableLooking for participantsNCT05254197
What this trial is testing

SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)

Who this might be right for
Brain Tumor, PrimaryMeningiomaSchwannoma+2 more
Seoul National University Hospital 3,000
Not applicableStudy completedNCT05021159
What this trial is testing

Assessing the Ontogeny of P-glycoprotein Expression in Blood of Pediatric Leukemic Patients

Who this might be right for
Acute Lymphocytic Leukemia
Tanta University 20
Not applicableEnrolling By InvitationNCT06709040
What this trial is testing

Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters

Who this might be right for
Growth Hormone DeficiencyNeoplasmsDiabetes Mellitus Type 2
Novo Nordisk A/S 500
Not applicableUnknownNCT02575352
What this trial is testing

Calcium Phosphate Cement Registry (CPC Registry)

Who this might be right for
Bone DiseaseFracture BoneBone Cyst
Graftys SA 500
Not applicableUnknownNCT04122885
What this trial is testing

Study of Plasma Tumor-promoting Factors and Immune Function After Laparotomy, Cytoreductive Surgery and HIPEC vs. PIPAC in Patients With Peritoneal Metastasis

Who this might be right for
Peritoneal CancerChemotherapy-Induced Change
University Hospital Tuebingen 60
Testing effectiveness (Phase 2)UnknownNCT02407366
What this trial is testing

Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
People's Hospital of Guangxi Zhuang Autonomous Region 80
Early research (Phase 1)Not Yet RecruitingNCT04933422
What this trial is testing

CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)

Who this might be right for
Glioblastoma
Crimson Biopharm Inc. 72
Large-scale testing (Phase 3)Study completedNCT00079066
What this trial is testing

Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer

Who this might be right for
Colorectal CancerQuality of Life
NCIC Clinical Trials Group 572
Next Page